Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Viatris Inc. - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
VTRS
Nasdaq
8071
www.viatris.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Viatris Inc.
Assessing Viatris (VTRS) Valuation After Its Recent Share Price Rebound
- May 7th, 2026 6:26 pm
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
- May 7th, 2026 2:30 pm
Viatris (VTRS) Q1 2026 Earnings Transcript
- May 7th, 2026 2:11 pm
Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater China
- May 7th, 2026 11:37 am
Here's What Key Metrics Tell Us About Viatris (VTRS) Q1 Earnings
- May 7th, 2026 7:30 am
Viatris (VTRS) Q1 Earnings and Revenues Surpass Estimates
- May 7th, 2026 6:50 am
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue
- May 7th, 2026 5:19 am
Viatris Reports First-Quarter 2026 Financial Results
- May 7th, 2026 4:59 am
Exploring Analyst Estimates for Viatris (VTRS) Q1 Earnings, Beyond Revenue and EPS
- May 6th, 2026 7:15 am
Are Wall Street Analysts Bullish on Viatris Stock?
- May 6th, 2026 4:55 am
Viatris Gears Up to Report Q1 Earnings: What's in the Cards?
- May 5th, 2026 11:16 am
Viatris Announces Quarterly Dividend
- May 5th, 2026 4:59 am
Edwards names Theodora Mistras as CFO
- May 5th, 2026 3:36 am
Edwards Lifesciences Announces Appointment of CFO
- May 4th, 2026 2:45 pm
Viatris Announces Chief Financial Officer Transition
- May 4th, 2026 2:30 pm
Is It Too Late To Consider Viatris (VTRS) After Its Strong One Year Share Price Run
- May 3rd, 2026 5:10 am
Chlorpheniramine Maleate - Global Market Insights, Competitive Landscape & Industry Forecast to 2033 Featuring Viatris, Alkem Labs, Merck & Co., Johnson & Johnson, Capellon Pharma and More
- May 1st, 2026 7:45 am
Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting
- May 1st, 2026 4:59 am
Is Viatris (VTRS) One of the Best Medical Stocks to Buy Under $30?
- Apr 30th, 2026 3:41 pm
Viatris (VTRS) Earnings Expected to Grow: Should You Buy?
- Apr 30th, 2026 8:00 am
Scroll